Biotech

All Articles

Praxis epilepsy medicine minimizes seizures in phase 2 hearing

.Praxis Preciseness Medicines has actually scored yet another midphase gain in epilepsy this year, w...

Three execs surrender as Dyne messages mixed information for DMD applicant

.After escaping a medical hold many years back, Dyne Therapy has actually shown brand-new stage 1/2 ...

Arrowhead fires off phase 3 records in rare metabolic condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its hand before a prospective face-off with Ionis, pos...

Pfizer, Valneva reveal lyme illness shot successful for second enhancer

.Pfizer and Valneva may possess regarding 2 even more years to stand by before they create the very ...

Fierce Biotech Managing Editor Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Let's dive into a conversation with Ayla Ellison, Tough Biotech Managing Editor and also Michelle B...

New records demonstrate how Bayer's asundexian fell short to prevent movements

.Bayer suspended the stage 3 test for its factor XIa prevention asundexian behind time in 2014 after...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

.Sanofi is still set on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, executives h...

Galapagos' stockpile as fund shows intent to form its own progression

.Galapagos is actually coming under added tension from clients. Having created a 9.9% concern in Gal...

Cell- focused Sana gathers initial CSO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of notable management hirings, shootings and...

Allist pays off Jacobio $21M, landing task in Chinese KRAS nationality

.Shanghai Allist Pharmaceuticals has actually gotten itself a starring role in China's KRAS market, ...